IVF INVO Fertility, Inc.
USHealthcareAs of 2026-10-08
Why IVF matters now
INVO Fertility, Inc. (IVF) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.74 with +0.35% on the session and $1.3M in market capitalization; recent performance reads 1-month +4.90% and YTD -60.11%.
The latest financial table shown here is Q4 2025, with revenue of $1.6M, net income of $475.5K, and EPS of $2.96. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -338.0%.
The latest indexable market news headline is "INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $20.00; recent insider activity includes Krigsvold Terah Renee filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.10
P/S
0.31
EV/EBITDA
-1.35
DCF Value
$-309.22
FCF Yield
-338.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.1%
Operating Margin
-103.8%
Net Margin
-340.9%
ROE
-490.0%
ROA
-115.3%
ROIC
-62.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.6M | $475.5K | $2.96 |
| FY 2025 | $6.8M | $-23.3M | $-66.11 |
| Q3 2025 | $1.8M | $-2.6M | $-1.87 |
| Q2 2025 | $1.9M | $-3.8M | $-22.88 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$20.00
Target (Median)
$20.00
Target Range
$20.00 - $20.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
2.33
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.